Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

JSR Will Buy Swiss Selexis to Expand Biopharma Business

Filed Under: Industry, Pharma Tagged With: , , ,

JSR Corp. (TYO:4185) has announced plans to acquire Selexis SA, a company with specialized cell line generation technology. The Swiss…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

JSR Pursues New Developments in Life Sciences Business
JSR Pursues New Developments in Life Sciences Business
AGC in Race to Bolster CDMO Operations Across US, Europe and Japan
AGC in Race to Bolster CDMO Operations Across US, Europe and…
Chitose Bio Evolution Moves Forward on Chemical, Bio-CDMO Mass Production in Japan
Chitose Bio Evolution Moves Forward on Chemical, Bio-CDMO…
AGC Looks to Advance Into Gene and Cell Therapy Business With Tender Offer for MolMed
AGC Looks to Advance Into Gene and Cell Therapy Business…
Sekisui Chemical to Build New Biopharmaceutical Plant in UK
Sekisui Chemical to Build New Biopharmaceutical Plant in UK
Asahi Kasei Medical to Enter Pharmaceutical CDMO Business
Asahi Kasei Medical to Enter Pharmaceutical CDMO Business